The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Mobius Therapeutics sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Mobius Therapeutics LLC, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Mobius Therapeutics LLC (Mobius Therapeutics) is a medical equipment company that develops sterile injectable pharmaceuticals. The company provides ophthalmic surgery solutions and supplies medical devices for treating glaucoma. Its Mitosol (mitomycin for solution) is a 0.2 mg and vial kit for ophthalmic use and also delivers antifibrotic agents in glaucoma, refractive, corneal surgery, and others. Mobius Therapeutics ophthalmology provides assured dosing, potency, and sterility, room temperature, ambient light storage, extended shelf life, strictly minimized contact potential, elimination of aerosolization, and others. The company caters hospitals, clinics, glaucoma surgeons, and others. Mobius Therapeutics is headquartered in Saint Louis, Missouri, the US.

The key metrics of Mobius Therapeutics related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Mobius Therapeutics is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Mobius Therapeutics.

For a detailed understanding of the performance of Mobius Therapeutics, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.